TELY Stock Chart & Stats
C$3.00
--
Market closed
C$3.00
--
Day’s Range― - ―
52-Week RangeC$0.30 - C$4.25
Previous CloseN/A
VolumeN/A
Average Volume (3M)35.69K
Market Cap
C$66.44M
Enterprise ValueC$103.50
Total Cash (Recent Filing)N/A
Total Debt (Recent Filing)N/A
Price to Earnings (P/E)―
Beta0.04
Next Earnings
Mar 31, 2027EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.12
Shares Outstanding26,788,006
10 Day Avg. Volume93,981
30 Day Avg. Volume35,688
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
P/FCF RatioN/A
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)-0.22
Revenue Forecast (FY)C$108.90M
TelyRx Holdings Inc. News
TELY FAQ
What was TelyRx Holdings Inc.’s price range in the past 12 months?
TelyRx Holdings Inc. lowest stock price was C$0.30 and its highest was C$4.25 in the past 12 months.
What is TelyRx Holdings Inc.’s market cap?
TelyRx Holdings Inc.’s market cap is C$66.44M.
When is TelyRx Holdings Inc.’s upcoming earnings report date?
TelyRx Holdings Inc.’s upcoming earnings report date is Mar 31, 2027 which is in 198 days.
How were TelyRx Holdings Inc.’s earnings last quarter?
TelyRx Holdings Inc. released its earnings results on Aug 10, 2026. The company reported -C$0.125 earnings per share for the quarter, missing the consensus estimate of -C$0.055 by -C$0.069.
Is TelyRx Holdings Inc. overvalued?
According to Wall Street analysts TelyRx Holdings Inc.’s price is currently Overvalued.
Does TelyRx Holdings Inc. pay dividends?
TelyRx Holdings Inc. does not currently pay dividends.
What is TelyRx Holdings Inc.’s EPS estimate?
TelyRx Holdings Inc.’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does TelyRx Holdings Inc. have?
TelyRx Holdings Inc. has 26,788,006 shares outstanding.
What happened to TelyRx Holdings Inc.’s price movement after its last earnings report?
TelyRx Holdings Inc. reported an EPS of -C$0.125 in its last earnings report, missing expectations of -C$0.055. Following the earnings report the stock price went down -11.111%.
Which hedge fund is a major shareholder of TelyRx Holdings Inc.?
Currently, no hedge funds are holding shares in TSE:TELY
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
TelyRx Holdings Inc. Stock Smart Score
Underperform
1
2
3
4
5
6
7
8
9
10
Fundamentals
Return on Equity
―
Trailing 12-Months
Asset Growth
5003.14%
Trailing 12-Months
Learn more about TipRanks Smart Score
Company Description
TelyRx Holdings Inc.
TelyRx Holdings Inc. operates as a vertically integrated technology-enabled healthcare and pharmacy services company which develops and operates a digital pharmacy platform. Its platform connects patients nationwide with physicians for access to everyday prescriptions. The company also operates pharmacies which ship the medicine to the patient's door with next-day delivery. It caters to doctors, veterinarians, practice groups, and other licensed prescribers. The company is based in Clearwater, Florida.
Technical Analysis
CareRx
―
Pharmadrug
―
Comprehensive Healthcare Systems Inc
―
CareSpan Health
―
UniDoc Health Corp
―